Showing results (521-530 of 628) with videos related to
Sort By:
Pageof 63
Insect Biochemistry and Molecular Biology|November 16, 2016
Ryanodine receptor point mutations confer diamide insecticide resistance in tomato leafminer, Tuta absoluta (Lepidoptera: Gelechiidae)Emmanouil Roditakis, Denise Steinbach, Gerald Moritz, et al.Bioorganic & Medicinal Chemistry Letters|February 3, 2005
Structure-guided design of pyrazolo[1,5-a]pyrimidines as inhibitors of human cyclin-dependent kinase 2Douglas S Williamson, Martin J Parratt, Justin F Bower, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 26, 2016
Tumourigenic non-small-cell lung cancer mesenchymal circulating tumour cells: a clinical case studyC J Morrow, F Trapani, R L Metcalf, et al.Science Advances|May 10, 2023
Functional neuronal circuits promote disease progression in cancerAnthony C Restaino, Austin Walz, Samuel J Vermeer, et al.ACS Omega|August 29, 2019
Establishing Drug Discovery and Identification of Hit Series for the Anti-apoptotic Proteins, Bcl-2 and Mcl-1James B Murray, James Davidson, Ijen Chen, et al.Journal of Medicinal Chemistry|October 13, 2017
Design of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors Using a Crystallographic Surrogate Derived from Checkpoint Kinase 1 (CHK1)Douglas S Williamson, Garrick P Smith, Pamela Acheson-Dossang, et al.Bioorganic & Medicinal Chemistry Letters|April 15, 2008
Antagonists of the human adenosine A2A receptor. Part 1: Discovery and synthesis of thieno[3,2-d]pyrimidine-4-methanone derivativesRoger J Gillespie, David R Adams, David Bebbington, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2022
Bendamustine is safe and effective for lymphodepletion before tisagenlecleucel in patients with refractory or relapsed large B-cell lymphomasG Ghilardi, E A Chong, J Svoboda, et al.Nature Medicine|January 3, 2024
A candidate antibody drug for prevention of malariaKatherine L Williams, Steve Guerrero, Yevel Flores-Garcia, et al.Clinical Immunology (Orlando, Fla.)|October 17, 2017
Non-progressing cancer patients have persistent B cell responses expressing shared antibody paratopes that target public tumor antigensJeff DeFalco, Michael Harbell, Amy Manning-Bog, et al.Pageof 63